Literature DB >> 148243

Role of circulating soluble immune complexes in disease.

R J Levinsky.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 148243      PMCID： PMC1545332          DOI： 10.1136/adc.53.2.96

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  21 in total

1.  Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.

Authors:  J S Cameron; M H Lessof; C S Ogg; B D Williams; D G Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  Nephrotic syndrome with pollen hypersensitivity.

Authors:  J HARDWICKE; J F SOOTHILL; J R SQUIRE; G HOLTI
Journal:  Lancet       Date:  1959-03-07       Impact factor: 79.321

3.  Evidence for the involvement of IgE-basophil system in acute serum sickness.

Authors:  J Benveniste; J Egido; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

Review 4.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

Review 5.  Immune complex disease in experimental animals and man.

Authors:  C G Cochrane; D Koffler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

6.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

7.  Experimental chronic glomerulitis.

Authors:  T Pincus; R Haberkern; C L Christian
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

8.  A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

Authors:  G Lagrue; S Xheneumont; A Branellec; G Hirbec; B Weil
Journal:  Biomedicine       Date:  1975-02-10

9.  The inhibition of complement-dependent lymphocyte rosette formation by the sera of children with steroid-sensitive hephrotic syndrome and other renal diseases.

Authors:  M D Smith; T M Barratt; A R Hayward; J F Soothill
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

10.  A receptor for the third component of complement in the human renal glomerulus.

Authors:  M C Gelfand; M M Frank; I Green
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307
View more
  5 in total

1.  The use of C1q, conglutinin and low affinity rabbit IgM antibody to human Fc in a ligand coctail radioassay for detecting and characterizing immune complexes in pathological sera.

Authors:  G D Harkiss; D L Brown
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

2.  A new cryopathic syndrome.

Authors:  M Caudron; C Bieva; E Laurent; F De Meuter; W W Feremans; P Lebas; C L Malmendier
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

3.  The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.

Authors:  Chokchai Thanadetsuntorn; Pintip Ngamjanyaporn; Chavachol Setthaudom; Kenneth Hodge; Nisara Saengpiya; Prapaporn Pisitkun
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

4.  Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.

Authors:  Haizhang Chen; Andrea Maul-Pavicic; Martin Holzer; Magdalena Huber; Ulrich Salzer; Nina Chevalier; Reinhard E Voll; Hartmut Hengel; Philipp Kolb
Journal:  EMBO Mol Med       Date:  2021-11-29       Impact factor: 12.137

5.  Circulating multimeric immune complexes contribute to immunopathology in COVID-19.

Authors:  Jakob Ankerhold; Sebastian Giese; Philipp Kolb; Andrea Maul-Pavicic; Reinhard E Voll; Nathalie Göppert; Kevin Ciminski; Clemens Kreutz; Achim Lother; Ulrich Salzer; Wolfgang Bildl; Tim Welsink; Nils G Morgenthaler; Andrea Busse Grawitz; Florian Emmerich; Daniel Steinmann; Daniela Huzly; Martin Schwemmle; Hartmut Hengel; Valeria Falcone
Journal:  Nat Commun       Date:  2022-09-26       Impact factor: 17.694
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.